Enzene Biosciences Ltd. obtains Marketing Authorization for its Romiplostim Biosimilar drug in India
PUNE, India, Aug. 20, 2021 /PRNewswire/ — Enzene Biosciences Ltd. “Enzene” announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its second biosimilar drug…
